Links

Zhejiang LangHua Pharmaceutical Co.,LTD.

Viva BioInnovator

©Viva Biotech (Shanghai) Ltd. 沪ICP备12042930号   Powerd by 300.cn 

About Us
About Viva
Company Culture
Company History
Management Team
Honors
Services
Gene-to-Protein & Gene-to-Structure
Viva Engine for Lead Discovery
Membrane Protein Targeted Discovery Technology
Medicinal Chemistry
In Vitro Pharmacology
Antibody Discovery Service
Products
Cell Lines
Crystal Structures
GPCR Proteins
Antibody
Protein
News
Company news
Industry news
Careers
Senior Management Recruitment
Chemistry Positions
Biology Positions
Home page
>
Industry News
【R.S.V.P.】Viva Biotech 2021 Partnership Summit

【R.S.V.P.】Viva Biotech 2021 Partnership Summit
2021-02-09 16:16
A Cradle for Promising Biotech Companies from around the World
View details
Viva Biotech Awarded "Best Small and Medium Market Value Company"

Viva Biotech Awarded "Best Small and Medium Market Value Company"
2021-01-11 10:48
The cradle for promising biotechnology startups all around the world.
View details
QureBio’s Q-1802 Clinical Application Accepted by NMPA

QureBio’s Q-1802 Clinical Application Accepted by NMPA
2020-12-30 16:10
The first Claudin 18.2/PD-L1 bispecific antibody drug accepted by NMPA.
View details
Viva Biotech and Shanghai Biomedical Fund Announce the Cooperation to Jointly Build the Medical Innovation Achievement Transformation Platform

Viva Biotech and Shanghai Biomedical Fund Announce the Cooperation to Jointly Build the Medical Innovation Achievement Transformation Platform
2020-12-22 13:13
Viva Biotech will give full play to its capabilities and advantages as a one-stop comprehensive service platform for drug R&D.
View details
Viva Biotech and AlphaMa Reached Cooperation Agreement on IntelligentDEL (iDEL) Screening Platform

Viva Biotech and AlphaMa Reached Cooperation Agreement on IntelligentDEL (iDEL) Screening Platform
2020-12-22 12:36
Viva Biotech will cooperate with AlphaMa to provide clients AI-based DNA coding compound library screening technology.
View details
Page up
1
2
...
9